Pharma/Biotech Update: FDA To Review New Hemophilia B Medication
The United States Food and Drug Administration (FDA) has accepted for review CSL Behring’s Biologics License Application (BLA) for its long-acting fusion…
The United States Food and Drug Administration (FDA) has accepted for review CSL Behring’s Biologics License Application (BLA) for its long-acting fusion…
UPDATE 1/27/2015 13WMAZ reported this story – Bikers Rally to Raise Money for Warner Robins Boy – today. As it…
On this episode of “The Missing Factor,” Drew discusses the new year of 2015 and the goals he has set…
According to a recent news article released by the website MPR, CSL Behring is officially submitting a Biologistics License Application…
In a press release posted by Market Watch, Spark Therapeutics is now in collaborations with Pfizer Inc. for the development…
According to an article from The StarPhoenix, the Saskatchewan Bleeding Disorders Program created a phone application to help those with…
In an article posted Business Wire today, Biogen Idec announced they will present data on their hemophilia therapies at the 56th Annual Meeting of…
In an article released today by Yahoo News, Bayer Healthcare announced it will file for approval of its hemophilia drug Bay…
Pharmaceutical company Novo Nordisk is set to release data on upcoming hemophilia and bleeding disorders medications at the 56th Annual Meeting…
Good news for the those who have hemophilia B. According to a new report outlined in the New England Journal…